Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00VZF
|
|||
Former ID |
DIB007605
|
|||
Drug Name |
Merbarone
|
|||
Synonyms |
NSC-336628
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Pancreatic cancer [ICD-11: 2C10] | Discontinued in Phase 2 | [1] | |
Company |
Uniroyal Chemical Co Inc
|
|||
Structure |
Download2D MOL |
|||
Formula |
C11H9N3O3S
|
|||
Canonical SMILES |
C1=CC=C(C=C1)NC(=O)C2C(=O)NC(=S)NC2=O
|
|||
InChI |
1S/C11H9N3O3S/c15-8(12-6-4-2-1-3-5-6)7-9(16)13-11(18)14-10(7)17/h1-5,7H,(H,12,15)(H2,13,14,16,17,18)
|
|||
InChIKey |
JARCFMKMOFFIGZ-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 97534-21-9
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | DNA topoisomerase II (TOP2) | Target Info | Modulator | [2] |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000894) | |||
REF 2 | The DNA topoisomerase II catalytic inhibitor merbarone is genotoxic and induces endoreduplication. Mutat Res. 2012 Oct-Nov;738-739:45-51. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.